Allogenica
PrivateLast Round
Grant
Mar 19, 2025
Total Funding Raised
$3.22M
Company Overview
Allogenica is a biotechnology company developing universal allogeneic CAR-T cell therapies for the treatment of blood cancers, rare diseases, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allogenica Comparables
Compare Allogenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immugenia Inc. | 83% | |
| Roche Holding | 78% | |
| Allotera Therapeutics | 78% |
Allogenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 19, 2025 | ||||
| Seed | May 20, 2022 |
Key People
Founding team and executive leadership
Allogenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Health Angels Rhône-Alpes | Seed |
| Pulsalys | Seed |
| Aloe Private Equity | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$2.7M grant received from France 2030.
- May 20, 2022
$500K round with participation from Aloe Private Equity and Health Angels.
Allogenica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allogenica's valuation, stock price, and market status.
Is Allogenica a public or private company?
Allogenica is a private company.
What is the current stock price of Allogenica?
Allogenica is a private company with no public stock price. Caplight tracks Allogenica's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Allogenica worth (valuation)?
Valuation information for Allogenica is not publicly available.
Can I buy Allogenica stock?
Allogenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allogenica's last funding round?
Allogenica's most recent funding round was Grant on March 19, 2025.
Who are the main investors in Allogenica?
Key investors in Allogenica include France 2030, Health Angels Rhône-Alpes, Pulsalys, Aloe Private Equity.
Will Allogenica IPO soon?
No public IPO plans have been announced for Allogenica.
How can I track Allogenica secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allogenica's secondary market activity and sign up for updates.